BIO-key International, Inc. (BKYI)

NASDAQ:
BKYI
| Latest update: Jan 15, 2026, 7:46 PM

Stock events for BIO-key International, Inc. (BKYI)

BIO-key International's stock price declined by 57.99% from January 8, 2025, to January 7, 2026, with high volatility. Key events include a 49% jump in Q2 2025 revenue, a decline in Q3 2025 revenue to $1.55 million, a $3.1 million warrant exercise agreement, debt reduction, and Q1 2025 revenue of $1.6 million.

Demand Seasonality affecting BIO-key International, Inc.’s stock price

Analysis of BIO-key International's stock performance suggests some seasonality in demand. Buying BKYI stock in January has shown the highest probability of a positive return (63.64%), while August has the lowest probability (10.00%).

Overview of BIO-key International, Inc.’s business

BIO-key International, Inc. specializes in identity and access management (IAM) solutions, focusing on biometric security and digital identity verification within the cybersecurity industry. Established in 1993, the company develops and markets fingerprint identification biometric technology and software solutions for commercial, government, and education sectors. Its offerings include IAM platforms like BIO-key PortalGuard, biometric technologies, finger scanners, and other products like BIO-key VST and PocketKey™.

BKYI’s Geographic footprint

BIO-key International, Inc. is headquartered in Holmdel, New Jersey, and serves a global clientele. The company is expanding its market reach through partnerships, such as with IT2Trust in Nordic markets, and has secured deployments in the Middle East defense sector.

BKYI Corporate Image Assessment

BIO-key International has worked to enhance its brand reputation through strategic initiatives and product innovation. The company showcased its solutions at events like GITEX 2025 and the Gartner® IAM Summit. Strategic partnerships, product launches like the EcoID III USB fingerprint scanner, new deployments, and industry recognition have positively affected BIO-key's reputation.

Ownership

BIO-key International, Inc. has a diverse ownership structure. Institutional owners hold 4.59% of the common stock, while individuals and insiders hold 3.71%. The remaining 84.00% is held by the public and other investors. Major institutional owners include Vanguard Group Inc and Geode Capital Management, Llc. Significant individual and insider owners include Micron Technology Development Ltd and Thomas J. Colatosti.

Price Chart

$0.60

9.65%
(1 month)

Top Shareholders

The Vanguard Group, Inc.
0.54%
Geode Holdings Trust
0.48%
GFH CSEVA LLC
0.38%
Renaissance Technologies Holdings Corp.
0.30%
XTX Topco Ltd.
0.27%
Tower Research Capital LLC
0.03%
UBS Group AG
0.02%
SBI Holdings, Inc.
0.00%

Trade Ideas for BKYI

Today

Sentiment for BKYI

News
Social

Buzz Talk for BKYI

Today

Social Media

FAQ

What is the current stock price of BIO-key International, Inc.?

As of the latest update, BIO-key International, Inc.'s stock is trading at $0.60 per share.

What’s happening with BIO-key International, Inc. stock today?

Today, BIO-key International, Inc. stock is down by -9.65%, possibly due to news.

What is the market sentiment around BIO-key International, Inc. stock?

Current sentiment around BIO-key International, Inc. stock is negative, based on recent news, trading volume, and analyst opinions.

Is BIO-key International, Inc.'s stock price growing?

Over the past month, BIO-key International, Inc.'s stock price has decreased by -9.65%.

How can I buy BIO-key International, Inc. stock?

You can buy BIO-key International, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol BKYI

Who are the major shareholders of BIO-key International, Inc. stock?

Major shareholders of BIO-key International, Inc. include institutions such as The Vanguard Group, Inc. (0.54%), Geode Holdings Trust (0.48%), GFH CSEVA LLC (0.38%) ... , according to the latest filings.